This symposium is for the drug development professional who wants to know more about how therapies of a variety of modalities move from preclinical through to clinical proof of concept. The preclinical data required and nice to have for optimal development as well as clinical design, planning and execution needed for a successful transition into clinical development based on different therapeutic modalities will be discussed. Discussion will include the impact of changes in the guidance around animal usage in preclinical development on clinical planning and dose selection.

Light refreshments, beverages, and happy hour snacks will be provided throughout the day.